Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Account Payables (2016 - 2022)

Historic Change in Account Payables for RedHill Biopharma (RDHL) over the last 7 years, with Q4 2022 value amounting to -$554000.0.

  • RedHill Biopharma's Change in Account Payables rose 8452.95% to -$554000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$7.4 million, marking a year-over-year decrease of 679729.73%. This contributed to the annual value of -$2.1 million for FY2024, which is 12163.87% down from last year.
  • As of Q4 2022, RedHill Biopharma's Change in Account Payables stood at -$554000.0, which was up 8452.95% from $411000.0 recorded in Q3 2022.
  • Over the past 5 years, RedHill Biopharma's Change in Account Payables peaked at $6.8 million during Q2 2021, and registered a low of -$6.0 million during Q1 2022.
  • Its 5-year average for Change in Account Payables is -$28750.0, with a median of -$52500.0 in 2018.
  • As far as peak fluctuations go, RedHill Biopharma's Change in Account Payables plummeted by 523589.74% in 2018, and later skyrocketed by 237254.9% in 2020.
  • RedHill Biopharma's Change in Account Payables (Quarter) stood at -$543000.0 in 2018, then decreased by 12.34% to -$610000.0 in 2019, then surged by 917.05% to $5.0 million in 2020, then tumbled by 171.85% to -$3.6 million in 2021, then surged by 84.53% to -$554000.0 in 2022.
  • Its Change in Account Payables was -$554000.0 in Q4 2022, compared to $411000.0 in Q3 2022 and -$1.3 million in Q2 2022.